Sched2 infant vaccine schedule immunogenicity study

Phase 4, randomised trial of diphtheria toxoid + tetanus toxoid + acellular pertussis vaccine + inactivated poliovirus vaccine + haemophilus influenzae type b conjugate vaccine, Meningococcal group C polysaccharide conjugate vaccine, pneumococcal 7-valent conjugate vaccine and Hib-MenC-TT in meningococcal disease, pneumococcal disease, diphtheria and 4 more (2 arms), sponsored by Health Protection Agency. Primary endpoints: Protective antibody proportion at post-primary timepoints and Geometric mean antibody titres or concentrations at post-primary timepoints. Started Oct 2007; status: completed.